Figure 3. Best percent change in tumor size (sum of diameter of target lesions) compared with baseline for efficacy-evaluable patients treated with sulfatinib formulation 2 (N=28).
PNET: pancreatic neuroendocrine tumor.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.